ALT Earnings Altimmune, Inc.
Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Updated
Annual results
EPS
Revenue
Net income
Quarterly results
EPS
Revenue
Net income
Reported EPS history
1–44 of 44
| Q2 2026 | 2026-06-30 | -0.29 | 2026-08-12 | 10-Q |
| Q1 2026 | 2026-03-31 | -0.18 | 2026-05-13 | 10-Q |
| FY 2025 | 2025-12-31 | -1.00 | 2026-03-06 | 10-K |
| Q3 2025 | 2025-09-30 | -0.74 | 2025-11-06 | 10-Q |
| Q2 2026 | 2025-06-30 | -0.53 | 2026-08-12 | 10-Q |
| Q1 2026 | 2025-03-31 | -0.26 | 2026-05-13 | 10-Q |
| FY 2025 | 2024-12-31 | -1.34 | 2026-03-06 | 10-K |
| Q3 2025 | 2024-09-30 | -1.01 | 2025-11-06 | 10-Q |
| Q2 2025 | 2024-06-30 | -0.69 | 2025-08-12 | 10-Q |
| Q1 2025 | 2024-03-31 | -0.34 | 2025-05-13 | 10-Q |
| FY 2024 | 2023-12-31 | -1.66 | 2025-02-27 | 10-K |
| Q3 2024 | 2023-09-30 | -1.10 | 2024-11-12 | 10-Q |
| Q2 2024 | 2023-06-30 | -0.72 | 2024-08-08 | 10-Q |
| Q1 2024 | 2023-03-31 | -0.40 | 2024-05-09 | 10-Q |
| FY 2023 | 2022-12-31 | -1.81 | 2024-03-27 | 10-K |
| Q3 2023 | 2022-09-30 | -1.37 | 2023-11-07 | 10-Q |
| Q2 2023 | 2022-06-30 | -0.90 | 2023-08-10 | 10-Q |
| Q1 2023 | 2022-03-31 | -0.44 | 2023-05-11 | 10-Q |
| FY 2022 | 2021-12-31 | -2.35 | 2023-02-28 | 10-K |
| Q3 2022 | 2021-09-30 | -1.79 | 2022-11-10 | 10-Q |
| Q2 2022 | 2021-06-30 | -0.99 | 2022-08-11 | 10-Q |
| Q1 2022 | 2021-03-31 | -0.38 | 2022-05-12 | 10-Q |
| FY 2021 | 2020-12-31 | -1.91 | 2022-03-15 | 10-K |
| Q3 2021 | 2020-09-30 | -1.74 | 2021-11-09 | 10-Q |
| FY 2016 | 2016-12-31 | 2.95 | 2017-03-14 | 10-K |
| FY 2016 | 2016-09-30 | 1.67 | 2017-03-14 | 10-K |
| FY 2016 | 2016-06-30 | 0.12 | 2017-03-14 | 10-K |
| FY 2016 | 2016-03-31 | -0.02 | 2017-03-14 | 10-K |
| FY 2016 | 2015-12-31 | -0.05 | 2017-03-14 | 10-K |
| FY 2016 | 2015-09-30 | -0.02 | 2017-03-14 | 10-K |
| FY 2016 | 2015-06-30 | -0.04 | 2017-03-14 | 10-K |
| FY 2016 | 2015-03-31 | 0.02 | 2017-03-14 | 10-K |
| FY 2016 | 2014-12-31 | -0.17 | 2017-03-14 | 10-K |
| FY 2015 | 2014-09-30 | -0.08 | 2016-03-11 | 10-K |
| FY 2015 | 2014-06-30 | -0.01 | 2016-03-11 | 10-K |
| FY 2015 | 2014-03-31 | -0.04 | 2016-03-11 | 10-K |
| FY 2014 | 2013-12-31 | -0.08 | 2015-03-11 | 10-K |
| FY 2014 | 2013-09-30 | -0.08 | 2015-03-11 | 10-K |
| FY 2014 | 2013-06-30 | -0.02 | 2015-03-11 | 10-K |
| FY 2014 | 2013-03-31 | -0.04 | 2015-03-11 | 10-K |
| FY 2013 | 2012-12-31 | -0.03 | 2014-03-11 | 10-K |
| FY 2013 | 2012-09-30 | 0.00 | 2014-03-11 | 10-K |
| FY 2013 | 2012-06-30 | -0.02 | 2014-03-11 | 10-K |
| FY 2013 | 2012-03-31 | -0.06 | 2014-03-11 | 10-K |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.